Register entry

MAIA Pharmaceuticals, Inc.

Registered sites
0
Drug products
12
Live patents
13
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

13

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
ANGIOMAX RTUBIVALIRUDINMay 2039
BORTEZOMIBBORTEZOMIBSept 2042
SINCALIDESINCALIDEApr 2038
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
Baclofen (Intrathecal)baclofenINJECTIONANDA
Baclofen (Intrathecal)BaclofenINJECTIONANDA
BivalirudinBivalirudinINJECTION, SOLUTIONNDA
BortezomibbortezomibINJECTIONNDA
BortezomibbortezomibINJECTIONNDA
DaptomycinDaptomycinINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA
SODIUM PHENYLACETATE AND SODIUM BENZOATEsodium phenylacetate and sodium benzoateINJECTION, SOLUTION, CONCENTRATEANDA
SincalideSincalideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
Sodium Phenylacetate and Sodium BenzoateSodium Phenylacetate and Sodium BenzoateINJECTIONNDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.